[Tobramycin. Bacteriological studies and clinical activity in urinary and extra-urinary infections].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001419:Bacteria / Q000187:drug effects*; D001424:Bacterial Infections / Q000188:drug therapy*; D001996:Bronchopneumonia / Q000188:drug therapy; D004341:Drug Evaluation; D004697:Endocarditis, Bacterial / Q000188:drug therapy; D006801:Humans; D008826:Microbial Sensitivity Tests; D011704:Pyelonephritis / Q000188:drug therapy; D012141:Respiratory Tract Infections / Q000188:drug therapy*; D018805:Sepsis / Q000188:drug therapy*; D014031:Tobramycin / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D014552:Urinary Tract Infections / Q000188:drug therapy*
D000900:Anti-Bacterial Agents; D014031:Tobramycin
La tobramicina. Rilievi batteriologici ed attività clinica nelle infezioni urinarie ed extraurinarie.